Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | 4-(Trifluoromethyl)benzoyl chloride | HCID 67607 | — |
| Reactant | 1-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)-2-butylsulfonyl]piperazine.dihydrochloride | HCID 18659257 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | Diisopropyl Ether | HCID 7914 | — |
| Product | 1-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)-2-butylsulfonyl]-4-(4-trifluoromethylbenzoyl)piperazine | HCID 54470929 | — |
Reaction Steps
In dichloromethane (10 ml) was dispersed 1-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)-2-butylsulfonyl]piperazine.dihydrochloride (Compound 20, 0.20 g) obtained in Working Example 14. To the dispersion were added, under ice-cooling, triethylamine (0.20 ml) and 4-trifluoromethylbenzoyl chloride (0.13 g). The mixture was stirred for 30 minutes at room temperatures. The reaction mixture was then concentrated under reduced pressure. The concentrate was dissolved in ethyl acetate, washed with water, dried and concentrated. The concentrate was subjected to a silica gel chromatography (eluent: hexane/ethyl acetate=1/3) for purification. The object fraction was concentrated which was processed with hydrogen chloride, followed by adding thereto isopropylether to give 1-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)-2-butylsulfonyl]-4-(4-trifluoromethylbenzoyl)piperazine (Compound 24).hydrochloride (167 mg) as colorless powder.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05389663 |
|---|
| Source dataset | uspto-grants-1995_02 |
|---|
| ORD ID | ord-f5fdecc8c1af49f39c425a7f6c39529f |
|---|
| Source note | uspto-grants-1995_02 |
|---|